EUVIMEDEUVIMED entdecken
Open Access

Cannabinoid Receptor 1 Signaling in Embryo Neurodevelopment

Delphine Psychoyos, K Yaragudri Vinod, Jin Cao, Shan Xie, Richard L Hyson, Bogdan Wlodarczyk, Weimin He, Thomas B Cooper, Basalingappa L Hungund, Richard H Finnell

Birth Defects Research Part B: Developmental and Reproductive Toxicology · 2012-04 · 95 (2) · 137-150

DOI: 10.1002/bdrb.20348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Birth Defects Research Part B: Developmental and Reproductive Toxicology, online erschienen am 06.02.2012. Verfasst von Delphine Psychoyos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Environmental and Genetic Medicine, Texas A&M Health Science Center, Houston, Texas 77030, USA. dpsychoyos@ibt.tamhsc.edu. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCD NIH HHS, NIAAA NIH HHS, NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In utero exposure to tetrahydrocannabinol, the psychoactive component of marijuana, is associated with an increased risk for neurodevelopmental defects in the offspring by interfering with the functioning of the endocannabinoid ( eCB ) system. At the present time, it is not clearly known whether the eCB system is present before neurogenesis. Using an array of biochemical techniques, we analyzed the levels of CB 1 receptors, eCB s ( AEA and 2‐ AG ), and the enzymes ( NAPE‐PLD , DAGL α, DAGL β, MAGL , and FAAH ) involved in the metabolism of the eCB s in chick and mouse models during development. The findings demonstrate the presence of eCB system in early embryo before neurogenesis. The eCB system might play a critical role in early embryogenesis and there might be adverse developmental consequences of in utero exposure to marijuana and other drugs of abuse during this period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsArachidonic AcidsCannabinoid Receptor ModulatorsChick EmbryoChromatography, LiquidDronabinolEmbryo, MammalianEndocannabinoidsEndpoint DeterminationFemaleGlyceridesMass SpectrometryMiceNeurogenesisPolyunsaturated AlkamidesProsencephalonReal-Time Polymerase Chain ReactionReceptor, Cannabinoid, CB1Signal TransductionSubstance-Related Disorders

Substanzen

Arachidonic AcidsCannabinoid Receptor ModulatorsEndocannabinoidsGlyceridesPolyunsaturated AlkamidesReceptor, Cannabinoid, CB1Dronabinolglyceryl 2-arachidonateanandamide

Autor:innen und Institutionen

  • Center for Environmental and Genetic Medicine, Texas A&M Health Science Center, Houston, Texas 77030, USA. dpsychoyos@ibt.tamhsc.edu

Förderung

  • NIDCD NIH HHS
  • NIAAA NIH HHS
  • NIDA NIH HHS

Zitieren

APA

Psychoyos, D., Vinod, K. Y., Cao, J., Xie, S., Hyson, R. L., Wlodarczyk, B., He, W., Cooper, T. B., Hungund, B. L., & Finnell, R. H. (2012). Cannabinoid Receptor 1 Signaling in Embryo Neurodevelopment. Birth Defects Research Part B: Developmental and Reproductive Toxicology, 95(2), 137-150. https://doi.org/10.1002/bdrb.20348

Vancouver

Psychoyos D, Vinod KY, Cao J, Xie S, Hyson RL, Wlodarczyk B, et al. Cannabinoid Receptor 1 Signaling in Embryo Neurodevelopment. Birth Defects Research Part B: Developmental and Reproductive Toxicology. 2012;95(2):137-150. doi:10.1002/bdrb.20348

BibTeX
@article{Psychoyos2012,
  author = {Psychoyos, Delphine and Vinod, K Yaragudri and Cao, Jin and Xie, Shan and Hyson, Richard L and Wlodarczyk, Bogdan and He, Weimin and Cooper, Thomas B and Hungund, Basalingappa L and Finnell, Richard H},
  title = {Cannabinoid Receptor 1 Signaling in Embryo Neurodevelopment},
  journal = {Birth Defects Research Part B: Developmental and Reproductive Toxicology},
  year = {2012},
  volume = {95},
  number = {2},
  pages = {137--150},
  doi = {10.1002/bdrb.20348}
}
Kostenlos starten →